Prosecution Insights
Last updated: April 19, 2026

Tiziana Life Sciences PLC

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18317810 NASAL FORMULATIONS OF FORALUMAB KIM, YUNSOO 1641 Non-Final OA May 15, 2023
18002591 CD-3 ANTIBODIES FOR THE TREATMENT OF CORONAVIRUS STEPHENS, AMELIA CAROLE 1645 Non-Final OA Dec 20, 2022
17927460 COMPOSITIONS AND METHODS FOR AUGMENTING CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPIES MARVICH, MARIA 1634 Final Rejection Nov 23, 2022

Managing Tiziana Life Sciences PLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month